HuGE Literature Finder
Records
1
-
30
| Next-Generation Sequencing in the Diagnosis of Metastatic Lesions: Reclassification of a Glioblastoma as an Endometrial Cancer Metastasis to the Brain. The oncologist 2021 Aug . Leung Shuk On Annie, Foley Olivia, Chapel David, Da Silva Annacarolina, Nucci Marisa, Muto Michael G, Campos Susa |
| Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread. Gynecologic oncology reports 2021 May 36 100720. Sullivan Stephanie A, Hawkins Gabriel, Zhao Xiobai, Jo Heejoon, Hayes Neil, Deng Xiaoyan, Bandyopadhyay Dipankar, Bae-Jump Victoria L, Rossi Emma |
| PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer. Gynecologic oncology 2021 Apr . Gonzalez-Bosquet Jesus, Bakkum-Gamez Jamie N, Weaver Amy L, McGree Michaela E, Dowdy Sean C, Famuyide Abimbola O, Kipp Benjamin R, Halling Kevin C, Couch Fergus J, Podratz Karl |
| Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer. Journal of translational medicine 2021 Feb 19 (1): 51. Feng Weiwei, Jia Nan, Jiao Haining, Chen Jun, Chen Yan, Zhang Yueru, Zhu Menghan, Zhu Chongying, Shen Lifei, Long Wenqi |
| Identification of prognostic and immune-related gene signatures in the tumor microenvironment of endometrial cancer. International immunopharmacology 2020 Sep 88 106931. Wang Guangwei, Wang Dandan, Sun Meige, Liu Xiaofei, Yang Qi |
| Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification. The American journal of surgical pathology 2020 May . Leskela Susanna, Romero Ignacio, Rosa-Rosa Juan M, Caniego-Casas Tamara, Cristobal Eva, Pérez-Mies Belén, Gutierrez-Pecharroman Ana, Santón Almudena, Ojeda Belén, López-Reig Raquel, Palacios-Berraquero María L, Andrada Encarna, Montes Santiago, Pastor Francisco, Gomez Maria C, López-Guerrero José A, Poveda Andrés, Palacios Jo |
| Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value? Reproductive sciences (Thousand Oaks, Calif.) 2020 Jan . Malentacchi Francesca, Turrini Irene, Sorbi Flavia, Projetto Elisabetta, Castiglione Francesca, Vergoni Federica, Amunni Gianni, Fambrini Massimiliano, Petraglia Felice, Noci Ivo, Pillozzi Sere |
| Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86). Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Jan . Dhani Neesha C, Hirte Hal W, Wang Lisa, Burnier Julia V, Jain Angela, Butler Marcus O, Welch Stephen, Fleming Gini F, Hurteau Jean, Matsuo Koji, Matei Daniela, Jimenez Waldo, Johnston Carolyn, Cristea Mihaela, Tonkin Katia, Ghatage Prafull, Lheureux Stephanie, Mehta Anjali, Quintos Judy, Tan Qian, Kamel-Reid Suzanne, Ludkovski Olga, Tsao Ming-Sound, Wright John J, Oza Amit |
| Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer. International journal of cancer 2019 Nov . Myers Andrea P, Konstantinopoulos Panagiotis A, Barry William T, Luo Weixiu, Broaddus Russell R, Makker Vicky, Drapkin Ronny, Liu Joyce, Doyle Austin, Horowitz Neil S, Meric-Bernstam Funda, Birrer Michael, Aghajanian Carol, Coleman Robert L, Mills Gordon B, Cantley Lewis C, Matulonis Ursula A, Westin Shannon |
| Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy. Gynecologic oncology reports 2019 Nov 30 100521. Octeau David, Abitbol Jeremie, Amajoud Zainab, Laskov Ido, Ferenczy Alex, Pelmus Manuela, Eisenberg Neta, Kessous Roy, Matanes Emad, Lau Susie, Yasmeen Amber, Lopez-Ozuna Vanessa, Salvador Shannon, Gotlieb Walter H, Kogan Lir |
| Molecular profiling and molecular classification of endometrioid ovarian carcinomas. Gynecologic oncology 2019 Jul . Cybulska Paulina, Paula Arnaud Da Cruz, Tseng Jill, Leitao Mario M, Bashashati Ali, Huntsman David G, Nazeran Tayyebeh M, Aghajanian Carol, Abu-Rustum Nadeem R, DeLair Deborah F, Shah Sohrab P, Weigelt Brit |
| Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer. Oncology reports 2019 Mar 41 (3): 1560-1574. Malentacchi Francesca, Turrini Irene, Sorbi Flavia, Projetto Elisabetta, Castiglione Francesca, Fambrini Massimiliano, Petraglia Felice, Pillozzi Serena, Noci I |
| Efficacy of liquid-based genetic diagnosis of endometrial cancer. Cancer science 2018 Oct . Matsuura Motoki, Yamaguchi Kiyoshi, Tamate Masato, Satohisa Seiro, Teramoto Mizue, Iwasaki Masahiro, Sugita Shintaro, Hasegawa Tadashi, Koubo Rika, Takane Kiyoko, Ikenoue Tsuneo, Furukawa Yoichi, Saito Tsuyos |
| Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors. Gynecologic oncology reports 2018 May 24 43-47. Kogan Liron, Octeau David, Amajoud Zainab, Abitbol Jeremie, Laskov Ido, Ferenczy Alex, Pelmus Manuela, Eisenberg Neta, Kessous Roy, Lau Susie, Yasmeen Amber, Gotlieb Walter H, Salvador Shann |
| Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas. Oncotarget 2018 Mar 9 (24): 17093-17103. Guttery David S, Blighe Kevin, Polymeros Konstantinos, Symonds R Paul, Macip Salvador, Moss Esther |
| Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecologic oncology 2017 Aug . Tarney Christopher M, Tian Chunqiao, Wang Guisong, Dubil Elizabeth A, Bateman Nicholas W, Chan John K, Elshaikh Mohamed A, Cote Michele L, Schildkraut Joellen M, Shriver Craig D, Conrads Thomas P, Hamilton Chad A, Maxwell G Larry, Darcy Kathleen |
| Identification of novel mutations in endometrial cancer patients by whole-exome sequencing. International journal of oncology 2017 Mar . Chang Ya-Sian, Huang Hsien-Da, Yeh Kun-Tu, Chang Jan-Gow |
| A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study). Cancer 2016 Sep . Makker Vicky, Recio Fernando O, Ma Ling, Matulonis Ursula A, Lauchle Jennifer O, Parmar Hema, Gilbert Houston N, Ware Joseph A, Zhu Rui, Lu Shan, Huw Ling-Yuh, Wang Yulei, Koeppen Hartmut, Spoerke Jill M, Lackner Mark R, Aghajanian Carol |
| Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study. Gynecologic oncology 2016 Apr 141 (1): 43-8. Myers Andrea P, Filiaci Virginia L, Zhang Yuping, Pearl Michael, Behbakht Kian, Makker Vicky, Hanjani Parviz, Zweizig Susan, Burke James J, Downey Gordon, Leslie Kimberly K, Van Hummelen Paul, Birrer Michael J, Fleming Gini |
| Genetic alterations in endometrial cancer by targeted next-generation sequencing. Experimental and molecular pathology 2015 Nov . Chang Ya-Sian, Huang Hsien-Da, Yeh Kun-Tu, Chang Jan-Gow |
| PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients. Molecular oncology 2015 Oct 9 (8): 1694-703. Westin Shannon N, Ju Zhenlin, Broaddus Russell R, Krakstad Camilla, Li Jane, Pal Navdeep, Lu Karen H, Coleman Robert L, Hennessy Bryan T, Klempner Samuel J, Werner Henrica M J, Salvesen Helga B, Cantley Lewis C, Mills Gordon B, Myers Andrea |
| Association of specific PTEN/10q haplotypes with endometrial cancer phenotypes in African-American and European American women. Gynecologic oncology 2015 Aug 138 (2): 434-40. Sutton Jazmine, Orloff Mohammed S, Michener Chad, Chiesa-Vottero Andres, Prayson Richard, Nowacki Amy S, Eng Char |
| Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jun 28 (6): 836-44. Stelloo Ellen, Bosse Tjalling, Nout Remi A, MacKay Helen J, Church David N, Nijman Hans W, Leary Alexandra, Edmondson Richard J, Powell Melanie E, Crosbie Emma J, Kitchener Henry C, Mileshkin Linda, Pollock Pamela M, Smit Vincent T, Creutzberg Carien |
| MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases. British journal of cancer 2014 Jun 110 (12): 2874-80. Nagy E, Gajjar K B, Patel I I, Taylor S, Martin-Hirsch P L, Stringfellow H F, Martin F L, Phillips D |
| Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. Oncotarget 2014 May 5 (10): 3029-38. Wheler Jennifer J, Moulder Stacy L, Naing Aung, Janku Filip, Piha-Paul Sarina A, Falchook Gerald S, Zinner Ralph, Tsimberidou Apostolia M, Fu Siqing, Hong David S, Atkins Johnique T, Yelensky Roman, Stephens Philip J, Kurzrock Razel |
| The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2014 May 24 (4): 713-7. Meyer Larissa A, Slomovitz Brian M, Djordjevic Bojana, Westin Shannon N, Iglesias David A, Munsell Mark F, Jiang Yunyun, Schmandt Rosemarie, Broaddus Russell R, Coleman Robert L, Galbincea John M, Lu Karen |
| Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome. Cancer 2013 Aug 119 (16): 3027-33. Huang Marilyn, Djordjevic Bojana, Yates Melinda S, Urbauer Diana, Sun Charlotte, Burzawa Jennifer, Daniels Molly, Westin Shannon N, Broaddus Russell, Lu Kar |
| High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. Gynecologic oncology 2013 Feb 128 (2): 327-34. Garcia-Dios Diego A, Lambrechts Diether, Coenegrachts Lieve, Vandenput Ingrid, Capoen An, Webb Penelope M, Ferguson Kaltin, , Akslen Lars A, Claes Bart, Vergote Ignace, Moerman Philippe, Van Robays Johan, Marcickiewicz Janusz, Salvesen Helga B, Spurdle Amanda B, Amant Frédér |
| PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? The oncologist 2013 18 (10): 1083-90. Mester Jessica L, Moore Rebekah A, Eng Char |
| Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study. Targeted oncology 2012 Dec . Trédan O, Treilleux I, Wang Q, Gane N, Pissaloux D, Bonnin N, Petit T, Cretin J, Bonichon-Lamichhane N, Priou F, Lavau-Denes S, Mari V, Freyer G, Lebrun D, Alexandre J, Ray-Coquard I |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: